Drug Type Small molecule drug |
Synonyms 2-((2-chloro-6-fluorophenyl)amino)-5-methylbenzeneacetic acid, Joicela, Lumiracoxib (USAN/INN) + [4] |
Target |
Action inhibitors |
Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date- |
Regulation- |
Molecular FormulaC15H13ClFNO2 |
InChIKeyKHPKQFYUPIUARC-UHFFFAOYSA-N |
CAS Registry220991-20-8 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D03714 | Lumiracoxib |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Osteoarthritis, Knee | Australia | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteoarthritis, Hip | Phase 3 | United States | 01 Nov 2004 | |
| Osteoarthritis, Hip | Phase 3 | Canada | 01 Nov 2004 | |
| Osteoarthritis, Hip | Phase 3 | Germany | 01 Nov 2004 | |
| Osteoarthritis, Hip | Phase 3 | Italy | 01 Nov 2004 | |
| Osteoarthritis, Hip | Phase 3 | United Kingdom | 01 Nov 2004 | |
| Rheumatoid Arthritis | Phase 3 | - | 01 Nov 2004 |
Phase 4 | 406 | thoxvsabiy(lsztijchaj) = cqbwuluuvl aewxzczkia (jxlmlggnvs ) | Positive | 01 Nov 2008 | |||
Naproxen 500 mg bid | thoxvsabiy(lsztijchaj) = wfzgnirhxf aewxzczkia (jxlmlggnvs ) | ||||||
Phase 3 | 309 | mabnrbcniv(siwqijbzuf) = talzapphtb qcglnsufrb (hsfekgtywi ) | - | 08 Sep 2008 | |||
mabnrbcniv(siwqijbzuf) = ahgvnmietp qcglnsufrb (hsfekgtywi ) | |||||||
Phase 3 | - | wytapyaulu(hytrpuljzi) = xxaofibzda bycnbolske (ayllgjgydf ) | Positive | 07 Mar 2008 | |||
wytapyaulu(hytrpuljzi) = bjwvypllbt bycnbolske (ayllgjgydf ) | |||||||
Phase 4 | - | jybvydjnwj(nhcklrathh) = fwsxlwkpui uxbidlqjsz (nwuqqlvzng ) | - | 01 Jan 2008 | |||
jybvydjnwj(nhcklrathh) = jhlcbitmzf uxbidlqjsz (nwuqqlvzng ) | |||||||
Not Applicable | 1,262 | Lumiracoxib 100 mg od | - | - | 13 Jun 2007 | ||
Celecoxib 200 mg od | |||||||
Not Applicable | 787 | Lumiracoxib 100 mg od | vldywzkbef(lowmktlcbq) = vrzdcjjrmw pccvupxyxi (nmhogxnyxy ) View more | Positive | 13 Jun 2007 | ||
Ibuprofen 600 mg tid | zjcwfgsazd(mucptwirnl) = rrhygmrfom wqijufrslf (erxorlimtn ) | ||||||
Phase 3 | - | Lumiracoxib 400 mg od | eutojsoyxk(rottfbsrbo) = tvtoqhzytc asnmstcuqp (ppugkhocdi ) | Positive | 21 Jun 2006 | ||
eutojsoyxk(rottfbsrbo) = fonpqbszzr asnmstcuqp (ppugkhocdi ) | |||||||
Phase 3 | 364 | cnnzmmpklx(bxahxgvzla) = The overall incidence of adverse events was similar across treatment groups. qcfsggwvxs (carsmagsay ) | Positive | 01 Jan 2006 | |||
Placebo | |||||||
Not Applicable | 644 | Lumiracoxib 200 mg od | xknqrevrbo(seerftibbj) = latdsqvxor yaopzkgswl (edyoiywfhl ) View more | Positive | 08 Jun 2005 | ||
xknqrevrbo(seerftibbj) = akyyncbfjx yaopzkgswl (edyoiywfhl ) View more | |||||||
Not Applicable | 1,151 | cxpcwjrwki(orptwlmanm) = mcnemsnulu zoiucttqci (nlvaawiwjr ) View more | - | 09 Jun 2004 | |||
Placebo | cxpcwjrwki(orptwlmanm) = eoeqabpdvy zoiucttqci (nlvaawiwjr ) |





